ADHD prescriptions in England surge by 18% since the pandemic

FHS
March 12, 2025
11:24 am

Prescriptions for attention deficit hyperactivity disorder (ADHD) in England have risen 18% year on year since the pandemic.

Targeting Novartis’ Scemblix, Enliven lays out case for leukemia drug in early results

Enliven Therapeutics released new Phase 1 data for its chronic myeloid leukemia program (CML) it hopes can eventually compete with Novartis’ Scemblix. The experimental therapy

October 2, 2024

Limited resources constrain federal oversight of medical device ads, GAO finds

Dive Brief: Federal agencies took 322 enforcement actions related to medical device advertising between 2018 and 2022, but their activities are constrained by resource limitations,

September 21, 2023

Oncology startup launches with $52 million, reflecting a new ‘austerity-driven’ financing reality

Tasca Therapeutics, the first startup created by new VC firm Cure Ventures, has raised $52 million to develop a new breed of cancer therapies. Tasca

December 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.